12.38
Prothena Corporation Plc (PRTA) 最新ニュース
Prothena Co. plc (NASDAQ:PRTA) Shares Acquired by Charles Schwab Investment Management Inc. - Defense World
Amundi Has $28,000 Stock Holdings in Prothena Co. plc (NASDAQ:PRTA) - Defense World
(PRTA) Technical Data - news.stocktradersdaily.com
Bank of New York Mellon Corp Has $2.08 Million Stake in Prothena Co. plc (NASDAQ:PRTA) - Defense World
Brokerages Set Prothena Co. plc (NASDAQ:PRTA) Target Price at $55.00 - Defense World
Zacks Research Has Positive Outlook of Prothena Q1 Earnings - Defense World
Insider Sell: Chief Medical Officer Hideki Garren Sells 2,000 Sh - GuruFocus.com
Zacks Research Weighs in on Prothena FY2027 Earnings - Defense World
Trend Tracker for (PRTA) - Stock Traders Daily
Recent Analysts’ Ratings Changes for Prothena (PRTA) - Defense World
Rhumbline Advisers Boosts Stake in Prothena Co. plc (NASDAQ:PRTA) - Defense World
Prothena Co. plc (NASDAQ:PRTA) Shares Purchased by Handelsbanken Fonder AB - Defense World
Prothena Corporation: Multiple Failures Make It Risky (NASDAQ:PRTA) - Seeking Alpha
Prothena (NASDAQ:PRTA) Stock Price Expected to Rise, Piper Sandler Analyst Says - Defense World
PROTHENA CORP PUBLIC LTD CO SEC 10-K Report - TradingView
Prothena Q4 Earnings Miss Estimates, Pipeline Progress in Focus - MSN
Prothena's SWOT analysis: neurodegenerative disease pipeline drives stock potential By Investing.com - Investing.com South Africa
Prothena's SWOT analysis: neurodegenerative disease pipeline drives stock potential - Investing.com India
Prothena (NASDAQ:PRTA) Rating Increased to Hold at StockNews.com - Defense World
Prothena Corp Stock: A Deep Dive Into Analyst Perspectives (9 Ratings) - Benzinga
Prothena’s (PRTA) “Buy” Rating Reiterated at HC Wainwright - Defense World
Prothena’s (PRTA) “Buy” Rating Reiterated at Chardan Capital - Defense World
Analysts Set Prothena Co. plc (NASDAQ:PRTA) PT at $46.50 - Defense World
Cantor Fitzgerald Reaffirms “Overweight” Rating for Prothena (NASDAQ:PRTA) - Defense World
Royal Bank of Canada Has Lowered Expectations for Prothena (NASDAQ:PRTA) Stock Price - Defense World
Prothena Corporation plc (NASDAQ:PRTA) Just Released Its Yearly Earnings: Here's What Analysts Think - Simply Wall St
Prothena Corporation plc (NASDAQ:PRTA) Q4 2024 Earnings Call Transcript - Insider Monkey
RBC Cuts Price Target on Prothena to $20 From $24, Keeps Sector Perform, Speculative Risk - Marketscreener.com
Prothena Corporation (NASDAQ: PRTA) Gears Up for Transformational 2025 with Key Clinical Milestones - Pradesh Tak
Earnings call transcript: Prothena's Q4 2024 results highlight innovation By Investing.com - Investing.com Australia
Prothena Corp PLC (PRTA) Q4 2024 Earnings Call Highlights: Strong Financial Position Amidst ... - Yahoo Finance
Earnings call transcript: Prothena's Q4 2024 results highlight innovation - Investing.com
Prothena: Q4 Earnings Snapshot -February 20, 2025 at 04:23 pm EST - Marketscreener.com
Prothena Reports Fourth Quarter and Full Year 2024 Financial Results, and Provides Financial Guidance and Business Highlights - Business Wire
(PRTA) Trading Advice - Stock Traders Daily
Prothena Corporation PLC expected to post a loss of $1.04 a shareEarnings Preview - TradingView
Kuehn Law Encourages Investors of Prothena Corporation PLC to Contact Law Firm - EIN News
The Prothena Corporation plc (PRTA) had a good session last reading, didn’t it? - US Post News
Merck KGaA bids for SpringWorks (SWTX), Evolus (EOLS) receives FDA nod & Prothena (PRTA) struggles - substack.com
Prothena to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025 - Business Wire
Alpha-Synuclein Inhibitors Clinical Trial Pipeline as Novel and Extensive 22+ Therapies Likely to Enter in the Domain | DelveInsight - GlobeNewswire Inc.
Focused Wealth Management Inc Makes New Investment in Prothena Co. plc (NASDAQ:PRTA) - MarketBeat
Critical Survey: Prothena (NASDAQ:PRTA) vs. Annexon (NASDAQ:ANNX) - Defense World
Prothena (PRTA) to Release Quarterly Earnings on Thursday - Defense World
Prothena (NASDAQ:PRTA) Given New $62.00 Price Target at Oppenheimer - MarketBeat
KALA BIO (NASDAQ:KALA) and Prothena (NASDAQ:PRTA) Financial Survey - Defense World
Prothena (NASDAQ:PRTA) Price Target Raised to $62.00 - Defense World
Form S-8Securities to be offered to employees in employee benefit plans - br.ADVFN.com
Learn to Evaluate (PRTA) using the Charts - Stock Traders Daily
Deep Dive Into Prothena Corp Stock: Analyst Perspectives (5 Ratings) - Benzinga
大文字化:
|
ボリューム (24 時間):